Dyskinesia, antipsychotic-drug exposure and risk factors in a developmentally-disabled population.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0091-3057(88)90271-7PMID 2451256
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dyskinetic symptoms in profoundly retarded residents following neuroleptic withdrawal and during methylphenidate treatment.

  2008cited by this paper
• Fluphenazine-induced acute and tardive dyskinesias in monkeys

  2004cited by this paper
• Initiation of levodopa therapy in parkinsonian patients should be delayed until the advanced stages of the disease.

  1986cited by this paper
• Integrating incidence and prevalence of tardive dyskinesia.

  1986cited by this paper
• Tardive dyskinesia in young mentally retarded individuals.

  1986cited by this paper
• Modification of Parkinson's disease by long-term levodopa treatment.

  1986cited by this paper
• Gilles de la Tourette's syndrome

  1986cited by this paper
• The prevalence of tardive dyskinesia in a mentally retarded population.

  1986cited by this paper
• Perioral behaviors induced by cholinesterase inhibitors: a controversial animal model.

  1986cited by this paper
• Vulnerability to tardive dyskinesia.

  1985cited by this paper
• Involuntary disorders of movement in chronic schizophrenia--the role of the illness and its treatment.

  1985cited by this paper
• Neuroleptic-related dyskinesias in autistic children: a prospective study.

  1985cited by this paper
• A national study of prescribed drugs in institutions and community residential facilities for mentally retarded people.

  1985cited by this paper
• Incidence of tardive dyskinesia: five-year data from a prospective study.

  1984cited by this paper
• Persistent tardive dyskinesia in randomly assigned neuroleptic reduction, neuroleptic nonreduction, and no-neuroleptic history groups: preliminary results.

  1984cited by this paper
• Incidence of tardive dyskinesia: five-year data from a prospective study.

  1984cited by this paper
• Tardive dyskinesia--animal models.

  1984cited by this paper
• Dystonic reactions and the pharmacokinetics of metoclopramide in children.

  1983cited by this paper
• Choreoathetosis associated with lithium: case report and literature review.

  1983cited by this paper
• Does tardive dyskinesia exist?

  1983cited by this paper
• Choreoathetosis associated with lithium: case report and literature review.

  1983cited by this paper
• Tardive dyskinesia in mentally retarded children, adolescents, and young adults: North Carolina and Michigan studies.

  1982cited by this paper
• Tardive dyskinesia: prevalence and risk factors, 1959 to 1979

  1982cited by this paper
• Fluphenazine decanoate and tardive dyskinesia: a possible association.

  1982cited by this paper
• Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics.

  1982cited by this paper
• Abnormal Involuntary Movements in Schizophrenia: Are They Related to the Disease Process or Its Treatment? Are They Associated with Changes in Dopamine Receptors?

  1982cited by this paper
• Tardive dyskinesia in psychiatric outpatients: a study of prevalence and association with demographic, clinical, and drug history variables

  1982cited by this paper
• Carbamazepine‐induced orofacial dyskinesia

  1980cited by this paper
• Tardive Dyskinesia and the Mentally Handicapped

  1980cited by this paper
• Tardive dyskinesia and other movement disorders in children treated with psychotropic drugs.

  1980cited by this paper
• Dystonia associated with carbamazepine administration: experience in brain-damaged children.

  1979cited by this paper
• Extrapyramidal syndrome with sodium valproate.

  1979cited by this paper
• Chorea induced by oral contraceptives

  1979cited by this paper
• Dyskinesias evoked in monkeys by weekly administration of haloperidol.

  1978cited by this paper
• Drug history and tardive dyskinesia.

  1978cited by this paper
• Oral-buccal dyskinesia symptoms associated with low-dose benzodiazepine treatment.

  1978cited by this paper
• Bilateral ballismus in phenytoin intoxication

  1978cited by this paper
• Athetosis and phenytoin toxicity.

  1977cited by this paper
• SPONTANEOUS BUCCOLINGUOFACIAL DYSKINESIA IN THE ELDERLY

  1977cited by this paper
• Phenytoin‐Induced Hyperkinesia

  1977cited by this paper
• Dyskinesia-an unusual reaction to ethosuximide.

  1975cited by this paper
• Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders.

  1975cited by this paper
• NEUROLOGICAL SYMPTOMS IN PHARMAGOTHERAPY OF PSYCHOSES

  1964cited by this paper
• NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES.

  1964cited by this paper

• A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs by D. G. Cunningham Owens

  2014cites this paper
• Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia

  2005cites this paper
• Tardive dyskinesia and pregnancy and delivery complications

  1996cites this paper
• Tardive akathisia in people with mental retardation

  1996cites this paper
• DYSKINETIC MOVEMENTS IN A POPULATION OF PEOPLE WITH LEARNING DISABILITIES

  1995cites this paper
• Constrasting effects of dopaminergic blockade on MDMA and d-amphetamine conditioned taste aversions

  1994cites this paper
• Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.

  1991cites this paper
• Tardive Dyskinesia and the Law

  1990cites this paper
• Schizophrenia, affective psychoses, and other disorders treated with neuroleptic drugs: the enigma of tardive dyskinesia, its neurobiological determinants, and the conflict of paradigms.

  1989cites this paper
• Lifetime antipsychotic-drug exposure, dyskinesia and related movement disorders in the developmentally disabled.

  1989cites this paper
• Prevalence and prediction of psychotropic drug use in California developmental centers.

  1989cites this paper